| [1] ESPOSITO F, FASANO E, SCOGNAMIGLIO G, et al. Exposure assessment to fumonisins B1, B2 and B3 through consumption of gluten-free foodstuffs intended for people affected by celiac disease[J]. Food Chem Toxicol, 2016, 97:395-401.
[2] WASKIEWICZ A, BESZTERDA M, GOLNSKI P. Occurrence of fumonisins in food-an interdisciplinary approach to the problem[J]. Food Control, 2012, 26(2):491-499.
[3] BORDINI J G, ONO M A, GARCIA G T, et al. Impact of industrial dry-milling on fumonisin redistribution in non-transgenic corn in Brazil[J]. Food Chem, 2017, 220:438-443.
[4] GELINEAU-VAN WAES J, VOSS K A, STEVENS V L, et al. Maternal fumonisin exposure as a risk factor for neural tube defects[J]. Adv Food Nutr Res, 2009, 56:145-181.
[5] ISLAMI F, KAMANGAR F, NASROLLAHZADEH D, et al. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran-a review[J]. Eur J Cancer, 2009, 45(18):3156-3165.
[6] ALIZADEH A M, ROSHANDEL G, ROUDBARMOHAMMADI S, et al. Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran[J]. Asian Pac J Cancer Prev, 2012, 13(6):2625-2628.
[7] 邱茂锋, 刘秀梅, 王玉华, 等. 某食管癌高发区人群伏马菌素摄入量及尿二氢神经鞘氨醇/神经鞘氨醇比值的调查[J]. 卫生研究, 2001, 30(6):365-367.
QIU M F, LIU X M, WANG Y H, et al. Survey on the fumonisins intake and the urinary Sa/So ratio of people suffered from a high incidence of esophageal cancer[J]. Journal of Hygiene Research, 2001, 30(6):365-367. (in Chinese)
[8] DUTTON M F. Fumonisins, mycotoxins of increasing importance:their nature and their effects[J]. Pharmacol Ther, 1996, 70(2):137-161.
[9] BONDY G S, SUZUKI C A M, FERNIE S M, et al. Toxicity of fumonisin B1 to B6C3F1 mice:a 14-day gavage study[J]. Food Chem Toxicol, 1997, 35(10-11):981-989.
[10] DOMBRINK-KURTZMAN M A. Fumonisin and beauvericin induce apoptosis in turkey peripheral blood lymphocytes[J]. Mycopathologia, 2003, 156(4):357-364.
[11] GBORE F A. Growth performance and puberty attainment in growing pigs fed dietary fumonisin B1[J]. J Anim Physiol Anim Nutr, 2009, 93(6):761-767.
[12] COLLINS T F X, SPRANDO R L, BLACK T N, et al. Effects of Fumonisin B1 in Pregnant Rats. Part 2[J]. Food Chem Toxicol, 1998, 36(8):673-685.
[13] GALVANO F, RUSSO A, CARDILE V, et al. DNA damage in human fibroblasts exposed to fumonisin B1[J]. Food Chem Toxicol, 2002, 40(1):25-31.
[14] RIEDEL S, ABEL S, BURGER H M, et al. Differential modulation of the lipid metabolism as a model for cellular resistance to fumonisin B1-induced cytotoxic effects in vitro[J]. Prostaglandins Leukot Essent Fatty Acids, 2016, 109:39-51.
[15] TOLLESON W H, MELCHIOR W J Jr, MORRIS S M, et al. Apoptotic and anti-proliferative effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells[J]. Carcinogenesis, 1996, 17(2):239-249.
[16] MARESCA M, YAHI N, YOUNèS-SAKR L, et al. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium:Stimulation of interleukin-8 secretion, potentiation of interleukin-1β effect and increase in the transepithelial passage of commensal bacteria[J]. Toxicol Appl Pharmacol, 2008, 228(1):84-92.
[17] ZHANG H, ZHANG L Y, DIAO X, et al. Toxicity of the mycotoxin fumonisin B1 on the insect Sf9 cell line[J]. Toxicon, 2017, 129:20-27.
[18] OSUCHOWSKI M F, SHARMA R P. Fumonisin B1 induces necrotic cell death in BV-2 cells and murine cultured astrocytes and is antiproliferative in BV-2 cells while N2A cells and primary cortical neurons are resistant[J]. NeuroToxicology, 2005, 26(6):981-992.
[19] BONDY G S, BARKER M G, LOMBAERT G A, et al. A comparison of clinical, histopathological and cell-cycle markers in rats receiving the fungal toxins fumonisin B1 or fumonisin B2 by intraperitoneal injection[J]. Food Chem Toxicol, 2000, 38(10):873-886.
[20] MOBIO T A, ANANE R, BAUDRIMONT I, et al. Epigenetic properties of fumonisin B1:cell cycle arrest and DNA base modification in C6 glioma cells[J]. Toxicol Appl Pharmacol, 2000, 164(1):91-96.
[21] PESTKA J J, ZHOU H R, MOON Y, et al. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes:unraveling a paradox[J]. Toxicol Lett, 2004, 153(1):61-73.
[22] MECA G, FERNÁNDEZ-FRANZÓN M, RITIENI A, et al. Formation of fumonisin B1-glucose reaction product, in vitro cytotoxicity, and lipid peroxidation on kidney cells[J]. J Agric Food Chem, 2010, 58(2):1359-1365.
[23] MARY V S, THEUMER M G, ARIAS S L, et al. Reactive oxygen species sources and biomolecular oxidative damage induced by aflatoxin B1 and fumonisin B1 in rat spleen mononuclear cells[J]. Toxicology, 2012, 302(2-3):299-307.
[24] DOMIJAN A M, ABRAMOV A Y. Fumonisin B1 inhibits mitochondrial respiration and deregulates calcium homeostasis-implication to mechanism of cell toxicity[J]. Int J Biochem Cell Biol, 2011, 43(6):897-904.
[25] POERSCH A B, TROMBETTA F, BRAGA A C M, et al. Involvement of oxidative stress in subacute toxicity induced by fumonisin B1 in broiler chicks[J]. Vet Microbiol, 2014, 174(1-2):180-185.
[26] HOU Q, CYMBALYUK E, HSU S C, et al. Apoptosis modulatory activities of transiently expressed Bcl-2:roles in cytochrome c release and Bax regulation[J]. Apoptosis, 2003, 8(6):617-629.
[27] WON S J, CHUNG K S, KI Y S, et al. CWJ-081, a novel 3-arylisoquinoline derivative, induces apoptosis in human leukemia HL-60 cells partially involves reactive oxygen species through c-Jun NH2-terminal kinase pathway[J]. Bioorg Med Chem Lett, 2010, 20(22):6447-6451.
[28] ZHAO Y Y, SHEN X, CHAO X, et al. Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells[J]. Biochim Biophys Acta, 2011, 1810(4):384-390.
[29] ALNEMRI E S. Mammalian cell death proteases:a family of highly conserved aspartate specific cysteine proteases[J]. J Cell Biochem, 1997, 64(1):33-42. |
